RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment.
Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
人类肠道微生物群与结直肠癌的发生和进展相关,操纵肠道微生物群是预防和治疗结直肠癌的一种新策略。一些细菌对结直肠癌具有抗肿瘤活性,其中特定细菌可以改善肿瘤微环境,激活包括树突状细胞、辅助性T细胞、NK 细胞和细胞毒性T细胞在内的免疫细胞,并上调白细胞介素-2和干扰素等促肿瘤免疫细胞因子的分泌。本文总结了一些在结直肠癌中具有潜在益处的细菌,描述了它们在肿瘤微环境中的作用,展示了肠道微生物与免疫抑制剂联合应用的情况,并为进一步的实验研究和临床实践应用提供了建议。
The human gut microbiota is associated with the development and progression of colorectal cancer, and manipulation of the gut microbiota is a novel strategy for the prevention and treatment of colorectal cancer. Some bacteria have antitumor activity against colorectal cancer, where specific bacteria can improve the tumor microenvironment, activate immune cells including dendritic cells, helper T cells, natural killer cells, and cytotoxic T cells, and upregulate the secretion of pro-tumor immune cytokines such as interleukin-2 and interferon.
In this paper, we summarize some bacteria with potential benefits in colorectal cancer and describe their roles in the tumor microenvironment, demonstrate the application of gut microbes in combination with immunosuppressive agents, and provide suggestions for further experimental studies and clinical practice applications.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。